TCF21 and coronary artery disorder: TCF21 was initially identified as a causal gene for coronary artery disease (CAD) but was first reported to regulate the phenotype switching of VSMCs to fibroblast‐like cells in atherosclerotic lesions of both mice and human samples [8].